| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARVN | Common Stock | Options Exercise | $387,200 | +20,000 | +25% | $19.36 | 98,645 | 15 Feb 2022 | Direct | F1 |
| transaction | ARVN | Common Stock | Sale | $420,899 | -5,867 | -5.9% | $71.74 | 92,778 | 15 Feb 2022 | Direct | F1, F2 |
| transaction | ARVN | Common Stock | Sale | $418,323 | -5,766 | -6.2% | $72.55 | 87,012 | 15 Feb 2022 | Direct | F1, F3 |
| transaction | ARVN | Common Stock | Sale | $304,004 | -4,126 | -4.7% | $73.68 | 82,886 | 15 Feb 2022 | Direct | F1, F4 |
| transaction | ARVN | Common Stock | Sale | $286,692 | -3,841 | -4.6% | $74.64 | 79,045 | 15 Feb 2022 | Direct | F1, F5 |
| transaction | ARVN | Common Stock | Sale | $22,740 | -300 | -0.38% | $75.80 | 78,745 | 15 Feb 2022 | Direct | F1, F6 |
| transaction | ARVN | Common Stock | Sale | $7,658 | -100 | -0.13% | $76.58 | 78,645 | 15 Feb 2022 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARVN | Stock Option (right to buy) | Options Exercise | $387,200 | -20,000 | -35% | $19.36 | 37,633 | 15 Feb 2022 | Common Stock | 20,000 | $19.36 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2021. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.14 to $72.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.15 to $73.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.16 to $74.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.16 to $75.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.52 to $76.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| F7 | This option award was granted on March 1, 2019. 1/4 of the shares underlying the award vested on March 1, 2020, with the remainder of the shares vesting in equal monthly installments through March 1, 2023. |